antibiotics

Petri dish of cultured Candida auris fungi
Biotech

Basilea secures $39M as part of BARDA antifungal funding plan

Basilea Pharmaceutica has accessed the next tranche of U.S. government funding required to continue developing its pipeline of new antifungals.
James Waldron Jul 8, 2025 3:52am
Petri dishes with different bacteria growing on them

Shionogi offers $600M for Swiss biotech's antibiotic program

Jul 2, 2025 1:00am
GSK

GSK's bet on rejected UTI antibiotic pays off with phase 3 win

May 28, 2025 8:42am
reshuffle pipeline target reorganize shift change

Spero halts development on another antibiotic

Mar 28, 2025 7:05am
drugs antibiotic

VC firm launches biotech aiming to counter antibiotic resistance

Feb 24, 2025 7:15am
MRSA comeback

Basilea opts not to take MRSA antibiotic into clinic

Feb 18, 2025 4:08am